Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir
Combination antiretroviral therapy (cART) is successfully used for prevention of perinatal HIV transmission. To investigate safety, we compared adverse events (AE) among infants exposed to different maternal cART regimens. We reviewed 158 HIV-uninfected infants born between 1997 and 2009, using logi...
Saved in:
Main Authors: | Christiana Smith (Author), Adriana Weinberg (Author), Jeri E. Forster (Author), Myron J. Levin (Author), Jill Davies (Author), Jennifer Pappas (Author), Kay Kinzie (Author), Emily Barr (Author), Suzanne Paul (Author), Elizabeth J. McFarland (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Tolerability of Antiretrovirals during Pregnancy
by: Adriana Weinberg, et al.
Published: (2011) -
Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy
by: Adriana Weinberg, et al.
Published: (2009) -
Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
by: Ashish Chandwani, et al.
Published: (2008) -
355 Lopinavir/ritonavir treatment in paediatric patients with covid-19
by: P Ip, et al.
Published: (2021) -
Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation
by: Wilhelm P. Greffrath, et al.
Published: (2018)